 |
296 Diseases |  |
92 Trials |
|
92 Trials |  |
3449 News |  |
| «12...37383940414243444546474849» |
- pioglitazone / Generic mfg.
Trial initiation date: Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity (clinicaltrials.gov) - Jan 15, 2013
P3, N=44, Recruiting, Sponsor: Baker Heart Research Institute
Initiation date: Jan 2008 --> Nov 2008
- pioglitazone / Generic mfg.
Enrollment open: Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity (clinicaltrials.gov) - Jan 15, 2013
P3, N=44, Recruiting, Sponsor: Baker Heart Research Institute
Initiation date: Jan 2008 --> Nov 2008 Not yet recruiting --> Recruiting
- pioglitazone / Generic mfg.
Enrollment closed: Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (clinicaltrials.gov) - Jan 2, 2013
P2, N=40, Active, not recruiting, Sponsor: University of Pittsburgh
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- |||| aleglitazar (R1439) / Roche
Trial completion: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment (clinicaltrials.gov) - Jan 2, 2013
P2, N=302, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
Clinical: Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women (clinicaltrials.gov) - Dec 11, 2012
P=N/A, N=40, Recruiting, Sponsor: Pennington Biomedical Research Center
- | atorvastatin / Generic mfg., pioglitazone / Generic mfg.
Trial initiation date: CUKCVC: The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) (clinicaltrials.gov) - Nov 22, 2012
P4, N=40, Completed, Sponsor: The Catholic University of Korea
Active, not recruiting --> Completed Initiation date: Jun 2009 --> Jun 2011
- | pioglitazone / Generic mfg.
New P4 trial: Pioglitazone for the Treatment of Bipolar Depression (clinicaltrials.gov) - Oct 28, 2012
P4, N=80, Recruiting, Sponsor: University Hospital Case Medical Center
- New P3 trial: clinical trial in adolescents with ovarian hyperandrogenism and hyperinsulinemia: Effects on ovulatory function, parameters of chronic inflammation, on cardiovascular risk factors and on risk factors for the development of type 2 diabetes Ensayo cl (EUDRACT) - Oct 28, 2012
P3, N=40, Ongoing, Sponsor: Fundaci
- | atorvastatin / Generic mfg., pioglitazone / Generic mfg.
Enrollment change: CUKCVC: The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) (clinicaltrials.gov) - Oct 23, 2012
P4, N=40, Completed, Sponsor: The Catholic University of Korea
Initiation date: Jun 2009 --> Jun 2011 N=100 --> 40
- | atorvastatin / Generic mfg., pioglitazone / Generic mfg.
Trial completion: CUKCVC: The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) (clinicaltrials.gov) - Oct 23, 2012
P4, N=40, Completed, Sponsor: The Catholic University of Korea
N=100 --> 40 Recruiting --> Completed
- MK-4074 / Merck (MSD)
Trial completion: Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) (clinicaltrials.gov) - Oct 15, 2012
P1, N=31, Completed, Sponsor: Merck
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| Daliresp (roflumilast) / AstraZeneca, Takeda, AbbVie
New P2 trial: Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis (clinicaltrials.gov) - Oct 8, 2012
P2, N=75, Recruiting, Sponsor: Takeda
- pioglitazone / Generic mfg.
Enrollment closed: POEM: Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI) (clinicaltrials.gov) - Oct 2, 2012
P2, N=300, Active, not recruiting, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- pioglitazone / Generic mfg.
Enrollment change, FDG PET: Anti-Inflammatory Effects of Pioglitazone (clinicaltrials.gov) - Sep 25, 2012
P=N/A, N=70, Completed, Sponsor: Kurume University
Recruiting --> Active, not recruiting N=100 --> 70
- pioglitazone / Generic mfg.
Trial completion, FDG PET: Anti-Inflammatory Effects of Pioglitazone (clinicaltrials.gov) - Sep 25, 2012
P=N/A, N=70, Completed, Sponsor: Kurume University
N=100 --> 70 Recruiting --> Completed
- ||| aleglitazar (R1439) / Roche
Enrollment change: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment (clinicaltrials.gov) - Sep 18, 2012
P2, N=302, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Completed N=302302 --> 302
- pioglitazone / Generic mfg.
Enrollment change: Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study (clinicaltrials.gov) - Aug 29, 2012
P4, N=0, Withdrawn, Sponsor: University of Minnesota - Clinical and Translational Science Institute
N=302302 --> 302 N=30 --> 0
- metformin / Generic mfg., pioglitazone / Generic mfg.
Enrollment change: TOSCA IT: Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial (clinicaltrials.gov) - Aug 19, 2012
P4, N=3371, Recruiting, Sponsor: Italian Society of Diabetology
N=30 --> 0 N=5172 --> 3371
- pioglitazone / Generic mfg.
Enrollment change: Pioglitazone for Lung Cancer Chemoprevention (clinicaltrials.gov) - Aug 6, 2012
P2, N=391, Recruiting, Sponsor: Department of Veterans Affairs
N=5172 --> 3371 N=126 --> 391
- ||| pioglitazone / Generic mfg.
Trial completion: Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants (clinicaltrials.gov) - Aug 5, 2012
P1, N=61, Completed, Sponsor: Takeda
N=126 --> 391 Recruiting --> Completed
- pioglitazone / Generic mfg.
Trial termination, IO biomarker: ADT: Androgen Deprivation Therapy Study (clinicaltrials.gov) - Aug 2, 2012
P=N/A, N=1, Terminated, Sponsor: National Institute on Aging (NIA)
Recruiting --> Completed Recruiting --> Terminated; No Participants completed study
- pioglitazone / Generic mfg.
Enrollment change, IO biomarker: ADT: Androgen Deprivation Therapy Study (clinicaltrials.gov) - Aug 2, 2012
P=N/A, N=1, Terminated, Sponsor: National Institute on Aging (NIA)
Recruiting --> Terminated; No Participants completed study N=60 --> 1
- pioglitazone / Generic mfg.
New P2 trial: Pioglitazone in Thyroid Cancers (clinicaltrials.gov) - Jul 31, 2012
P2, N=15, Recruiting, Sponsor: University of Michigan
- ||| pioglitazone / Generic mfg.
Clinical: Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes (clinicaltrials.gov) - Jul 9, 2012
P=N/A, N=200000, Active, not recruiting, Sponsor: Takeda
- | pioglitazone / Generic mfg.
New P2 trial: Piogliatazone for Alcohol Craving (clinicaltrials.gov) - Jun 27, 2012
P2, N=60, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- pioglitazone / Generic mfg.
Biomarker, Trial completion: Effect of Pioglitazone on Inflammation in Cystic Fibrosis (clinicaltrials.gov) - Jun 12, 2012
P1, N=24, Completed, Sponsor: Paul Beringer
N=60 --> 1 Recruiting --> Completed
- pioglitazone / Generic mfg.
Trial completion, Preclinical, Stroma: Effect of Thiazolidinediones on Human Bone (clinicaltrials.gov) - Jun 5, 2012
P=N/A, N=10, Completed, Sponsor: Emory University
Recruiting --> Completed Recruiting --> Completed
- ||||| Torisel (temsirolimus) / Pfizer
New P1/2 trial, Combination therapy, Metastases: Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma (clinicaltrials.gov) - Jun 5, 2012
P1/2, N=136, Recruiting, Sponsor: University of Regensburg
- | metformin / Generic mfg., pioglitazone / Generic mfg.
New P4 trial: Metabolic Abnormalities in HIV-infected Persons (clinicaltrials.gov) - Jun 4, 2012
P4, N=70, Recruiting, Sponsor: Tufts Medical Center
- pioglitazone / Generic mfg.
Enrollment change: Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin (clinicaltrials.gov) - Jun 3, 2012
P=N/A, N=6, Completed, Sponsor: Oregon Health and Science University
Recruiting --> Completed N=24 --> 6
- pioglitazone / Generic mfg.
Trial completion: Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin (clinicaltrials.gov) - Jun 3, 2012
P=N/A, N=6, Completed, Sponsor: Oregon Health and Science University
N=24 --> 6 Recruiting --> Completed
- pioglitazone / Generic mfg.
Trial completion: Effects of Pioglitazone in Hypertensive Patients (clinicaltrials.gov) - Jun 2, 2012
P4, N=16, Completed, Sponsor: Tottori University Hospital
Recruiting --> Completed Recruiting --> Completed
- pioglitazone / Generic mfg.
Trial completion: Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease (clinicaltrials.gov) - Jun 2, 2012
P2, N=184, Completed, Sponsor: Xin Gao
Recruiting --> Completed Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
Trial completion: Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus (clinicaltrials.gov) - May 29, 2012
P1, N=15, Completed, Sponsor: Stony Brook University
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| Suglat (ipragliflozin) / EMD Serono, Kotobuki, Astellas
Trial completion, Combination therapy: A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients (clinicaltrials.gov) - May 22, 2012
P3, N=152, Completed, Sponsor: Astellas Pharma Inc
Recruiting --> Completed Active, not recruiting --> Completed
- pioglitazone / Generic mfg.
Trial completion: PIO-TACE: Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes (clinicaltrials.gov) - May 3, 2012
P4, N=60, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| Jardiance (empagliflozin) / Eli Lilly, Boehringer Ingelheim
Combination therapy: Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin (clinicaltrials.gov) - May 1, 2012
P3, N=499, Completed, Sponsor: Boehringer Ingelheim
Recruiting --> Completed Active, not recruiting --> Completed
- | pioglitazone / Generic mfg.
New P4 trial: T2DMCT: Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects (clinicaltrials.gov) - Apr 30, 2012
P4, N=77, Completed, Sponsor: University of Dhaka
- pioglitazone / Generic mfg.
Enrollment closed: University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) (clinicaltrials.gov) - Apr 25, 2012
P4, N=90, Active, not recruiting, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- pioglitazone / Generic mfg.
Trial withdrawal, Immunomodulating: Endometriosis: Immunomodulation (clinicaltrials.gov) - Apr 24, 2012
P2/3, N=0, Withdrawn, Sponsor: University of Wisconsin, Madison
Recruiting --> Active, not recruiting Recruiting --> Withdrawn
- pioglitazone / Generic mfg.
Enrollment change, Immunomodulating: Endometriosis: Immunomodulation (clinicaltrials.gov) - Apr 24, 2012
P2/3, N=0, Withdrawn, Sponsor: University of Wisconsin, Madison
Recruiting --> Withdrawn N=140 --> 0
- pioglitazone / Generic mfg.
New P1 trial: Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Patients With Brain Tumors (clinicaltrials.gov) - Apr 24, 2012
P1, N=100, Recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
- pioglitazone / Generic mfg.
Enrollment closed: Inflammation and Insulin Resistance in Rheumatoid Arthritis (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=36, Active, not recruiting, Sponsor: Vanderbilt University
N=140 --> 0 Recruiting --> Active, not recruiting
- |||| mitoglitazone (MSDC-0160) / Metabolic Solutions
Trial completion: Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients (clinicaltrials.gov) - Apr 17, 2012
P2b, N=356, Completed, Sponsor: Metabolic Solutions Development Company
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
Trial completion, Combination therapy: Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone (clinicaltrials.gov) - Apr 3, 2012
P3, N=278, Completed, Sponsor: Boehringer Ingelheim
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | pioglitazone / Generic mfg.
New P4 trial: Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) (clinicaltrials.gov) - Mar 18, 2012
P4, N=50, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
- | pioglitazone / Generic mfg.
New P4 trial: Pioglitazone in Patients With Mood Disorders (clinicaltrials.gov) - Mar 15, 2012
P4, N=80, Recruiting, Sponsor: Stanford University
- glimepiride / Generic mfg., pioglitazone / Generic mfg.
Monotherapy: Phielix et al.: Hepatic Fat Content and Adipokines (clinicaltrials.gov) - Mar 13, 2012
P=N/A, N=24, Completed, Sponsor: German Diabetes Center
- pioglitazone / Generic mfg.
Trial completion, P2a data, Combination therapy: Combination Therapy in Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Mar 8, 2012
P2a, N=28, Completed, Sponsor: Phoenix Neurological Associates, LTD
Active, not recruiting --> Completed Recruiting --> Completed
- pioglitazone / Generic mfg.
Enrollment change: Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4? (clinicaltrials.gov) - Mar 8, 2012
P4, N=25, Completed, Sponsor: Baylor College of Medicine
Recruiting --> Completed N=110 --> 25